Logo Image
NP/PA Connect
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference ListingNP/PA Conferences
Events
NP/PA EventsCase-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
Awareness SpotlightInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Watch
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Anti-Aging
  • Artificial Intelligence
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hair & Scalp
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Spotlight -
NP/PA Connect|
Acne|
Atopic Dermatitis|
Chronic Hand Eczema|
Chronic Spontaneous Urticaria|
Drug Watch|
Hidradenitis Suppurativa|
Psoriasis|
Skin Cancer|
Vitiligo
Advertisement

Paula Moyer

Advertisement

Paula Moyer is a clinical writer based in Minnesota.

Articles by Paula Moyer

Derms may be first to spot cardiovascular risk in psoriasis patients

ByPaula Moyer
April 1st 2013

People who live with psoriasis have a higher risk of death from cardiovascular disease.

Advertisement

Latest Updated Articles

  • Derms may be first to spot cardiovascular risk in psoriasis patients
    Derms may be first to spot cardiovascular risk in psoriasis patients

    April 1st 2013



Advertisement
Advertisement

Trending on Dermatology Times

1

FDA Implements Updated iPLEDGE REMS Requirements for Isotretinoin

2

Monitoring and Treatment Selection for Oral TYK2 Inhibitors in Psoriasis

3

CIndU Patient Demographics: Disease Duration, Diagnostic Delay, and Quality of Life

4

Bioelements and Celluma Collaborate on LED Facial Treatments

5

Aclaris' Bosakitug Misses Phase 2 Endpoints in Atopic Dermatitis

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us